Q2 2020 Holdings
Filed 2020-08-14 | 42 holdings | $443.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $81.5M | 550,000 | 18.4% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $79.3M | 4,849,524 | 17.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $57.2M | 1,070,000 | 12.9% |
| Codexis Inc(CDXS) | COM | 192005106 | $53.5M | 4,692,732 | 12.1% |
| Caredx Inc(CDNA) | COM | 14167L103 | $42.3M | 1,193,335 | 9.5% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $34.5M | 713,125 | 7.8% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $28.3M | 150,000 | 6.4% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $26.8M | 625,000 | 6.0% |
| Alector Inc(ALEC) | COM | 014442107 | $26.3M | 1,076,039 | 5.9% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $12.2M | 289,395 | 2.8% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $273.6K | 9,033,943 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $120.9K | 1,550,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $104.6K | 3,050,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $85.0K | 530,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $84.1K | 870,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $67.4K | 1,105,000 | 0.0% |
| Burning Rock Biotech LTD | SPONSORED ADS | 12233L107 | $46.7K | 1,730,786 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $45.3K | 1,000,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $42.1K | 1,334,536 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $38.9K | 1,865,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $33.8K | 1,611,214 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $31.7K | 1,310,000 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $29.4K | 980,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $26.4K | 1,441,176 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $25.1K | 3,346,034 | 0.0% |
| Amyris Inc(AMRSEUR) | COM NEW | 03236M200 | $22.8K | 5,349,376 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $19.6K | 266,430 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $18.9K | 300,000 | 0.0% |
| Dermtech Inc(DMTKQ) | COM | 24984K105 | $18.9K | 1,428,572 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $15.6K | 190,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $13.0K | 1,455,000 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $12.3K | 1,850,373 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $11.1K | 30,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY-R) | RIGHT | 110122157 | $10.6K | 2,950,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $9.9K | 1,650,000 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $9.5K | 750,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $8.5K | 251,515 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $5.7K | 135,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $4.8K | 75,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $4.7K | 130,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $3.9K | 65,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.9K | 120,000 | 0.0% |